ethionamide and sulfoxide

A highly sensitive and specific LC-MS/MS method has been developed for simultaneous quantification of ethionamide and ethionamide sulfoxide in human plasma (300 µL) using prothionamide as an internal standard (IS). Solid-phase extraction was used to extract ethionamide, ethionamide sulfoxide and IS from human plasma. The chromatographic separation of ethionamide, ethionamide sulfoxide and IS was achieved with a mobile phase consisting of 0.1% acetic acid : acetonitrile (20:80, v/v) at a flow rate of 0.50 mL/min on a Peerless Basic C(18) column. The total run time was 3.5 min and the elution of ethionamide, ethionamide sulfoxide and IS occurred at 2.50, 2.18 and 2.68 min, respectively. A linear response function was established for the range of concentrations 25.7-6120 ng/mL (r > 0.998) for ethionamide and 50.5-3030 ng/mL (r > 0.998) for ethionamide sulfoxide. The intra- and inter-day precision values for ethionamide and ethionamide sulfoxide met the acceptance as per FDA guidelines. Ethionamide and ethionamide sulfoxide were stable in battery of stability studies, viz. bench-top, autosampler and freeze-thaw cycles. The developed assay was applied to a pharmacokinetic study in humans.

Topics: Antitubercular Agents; Chromatography, Liquid; Drug Stability; Ethionamide; Humans; Safrole; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization

Topics: Animals; Ethionamide; Mice; Mycobacterium tuberculosis; Pharmacology; Rabbits; Research; Safrole; Sulfoxides; Toxicology; Tuberculosis

Topics: Animals; Ethionamide; Polarography; Rabbits; Research; Safrole; Sulfoxides; Urine

Topics: Cerebrospinal Fluid; Ethionamide; Humans; Polarography; Safrole; Spectrophotometry; Sulfoxides